Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    21909049 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Condition: Pneumococcal Disease
Intervention: Biological: Pneumococcal (vaccine)
2 Completed Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™
Conditions: Streptococcus Pneumoniae;   Pneumococcal Disease;   Haemophilus Influenzae Infections
Interventions: Biological: Pneumococcal conjugate vaccine GSK 1024850A;   Biological: Pneumococcal conjugate vaccine Prevenar™ (Wyeth Lederle's)
3 Completed Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
Condition: Prophylaxis Pneumococcal Vaccine
Intervention: Biological: Pneumococcal vaccine

Indicates status has not been verified in more than two years